NEW YORK (TheStreet) -- CHANGE IN RATINGS
Abercrombie & Fitch (ANF) was downgraded to Market Perform at Wells Fargo. Estimates were also cut, given lower comp sales trends, Wells Fargo said.
Atmos Energy (ATO) was upgraded at Bank of America/Merrill Lynch from Neutral to Buy. $37 price target. Company can deliver above-average growth over the next few years, BofA/Merrill said.
CH Robinson (CHRW) was initiated with a Hold rating at Wunderlich. $68 price target. Company operates in a slow-growth market, where supply has caught up with demand, Wunderlich said.Cintas (CTAS) was downgraded at Keybanc from Buy to Hold. Company lacks near-term catalysts, Keybanc said. Dell (DELL) was upgraded at Sterne Agee from Underperform to Neutral. Valuation call, based on a $15 price target, Sterne Agee said. Deutsche Bank (DB) was downgraded to Sell at TheStreet Ratings. Eldorado Gold (EGO) was upgraded to Buy at TheStreet Ratings. Green Dot (GDOT) was downgraded at Goldman Sachs from Buy to Neutral. Company is facing increased competition, which could impede growth, Goldman said. $24 price target. Herbalife (HLF) was upgraded at Caris & Company from Average to Buy. $86 price target. Company has strong fundamentals and no longer appears to be on the radar of David Einhorn, Caris said. Helmerich & Payne (HP) was upgraded at Argus from Hold to Buy, Argus said. $55 price target. Valuation call, as the stock is down about 25% year-to-date, Argus said. Knight Transportation (KNX) was initiated with a Buy rating at Wunderlich. $20 price target. Company has resumed solid earnings growth, Wunderlich said. Legg Mason (LM) was upgraded at Citigroup to Buy from Neutral following capital plan including deleveraging and new buyback, Citigroup said. $32.50 price target. Company also added to TPL!. Riverbed (RVBD) was downgraded from Buy to Neutral at MKM Partners. $16.50 price target. Company is launching new products into a difficult macro environment, MKM said. Tyler Technologies (TYL) was initiated with a Buy rating at Benchmark. $45 price target. Company has good visibility and more than 50% recurring revenue, Benchmark said. Vitamin Shoppe (VSI) was downgraded at Deutsche Bank to Hold. Company lacks near-term catalysts. $54 price target.
STOCK COMMENTS / EPS CHANGESAbercrombie & Fitch numbers were cut at UBS. Shares are now seen reaching $60. Estimates were also lowered as European weakness continues, especially at Hollister, UBS said. Buy rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV